KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Accounts Payables (2016 - 2025)

Cvs Health (CVS) has disclosed Accounts Payables for 17 consecutive years, with $17.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 11.01% year-over-year to $17.6 billion, compared with a TTM value of $17.6 billion through Dec 2025, up 11.01%, and an annual FY2025 reading of $17.6 billion, up 11.01% over the prior year.
  • Accounts Payables was $17.6 billion for Q4 2025 at Cvs Health, down from $17.8 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $17.8 billion in Q3 2025 and bottomed at $10.8 billion in Q1 2021.
  • Average Accounts Payables over 5 years is $14.3 billion, with a median of $14.2 billion recorded in 2022.
  • The sharpest move saw Accounts Payables fell 1.66% in 2023, then rose 20.54% in 2025.
  • Year by year, Accounts Payables stood at $12.5 billion in 2021, then increased by 18.29% to $14.8 billion in 2022, then grew by 0.4% to $14.9 billion in 2023, then rose by 6.68% to $15.9 billion in 2024, then increased by 11.01% to $17.6 billion in 2025.
  • Business Quant data shows Accounts Payables for CVS at $17.6 billion in Q4 2025, $17.8 billion in Q3 2025, and $17.3 billion in Q2 2025.